KATONA CORNELIUS ET AL: "A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.", INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY JUL 2012, vol. 27, no. 4, July 2012 (2012-07), pages 215-223, ISSN: 1473-5857 (B1)

LARSEN KARI: "Lundbeck says antidepressant LuAA21004 positive in phase II - shares jump", INTERNET ARTICLE , 2 October 2007 (2007-10-02), XP002509653, Retrieved from the Internet: URL:http://health.apmnews.com/depechesPubl ieesDepeches.php?annee=2007&mois=10&jour=2 [retrieved on 2009-01-08] (B1)

MEALY N E ET AL: "Lu-31-130/Lu-AA-21004/Lu-35-138", DRUGS OF THE FUTURE 200409 ES, vol. 29, no. 9, September 2004 (2004-09), pages 954-955, XP009110475, ISSN: 0377-8282 (B1)

RASKIN JOEL ET AL: "Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial", AMERICAN JOURNAL OF PSYCHIATRY, AMERICAN PSYCHIATRIC PUBLISHING, INC, US, vol. 164, no. 6, 1 June 2007 (2007-06-01), pages 900-909, XP009175100, ISSN: 0002-953X (B1)

WO-A-2008/113359 (B1)

US-A1- 2006 019 938 (B1)

WO-A-03/029232 (B1)

WO-A-2007/144005 (B1)

RASKIN JOEL ET AL: "Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial", AMERICAN JOURNAL OF PSYCHIATRY, vol. 164, no. 6, June 2007 (2007-06), pages 900-909, ISSN: 0002-953X (B1)